Agreement between JUSTICE and Elsevier
Elsevier and JUSTICE (the Japan Alliance of University Library Consortia for E-Resources(opens in new tab/window)) have established an agreement to support authors in Japan who wish to publish open access. The cost of publishing open access is reduced under the terms of this agreement. Eligible corresponding authors receive a discount on the article publishing charge (APC).
How does the process work?
The process of publishing under the agreement is straightforward:
Step 1 – Once the journal accepts your article, you will receive an email containing a link to the “post acceptance author journey”.
Step 2 – You will be asked to review your affiliation and funder details. Based on this information, you will see personalised publishing options including the option to publish under the agreement.
Step 3 – You will confirm your publishing choices and complete the post acceptance journey.
Step 4 – Your institution will validate your eligibility for the agreement
Step 5 – You and your co-authors will receive an email to confirm that the APC discount will be applied.
During the submission process, the system will present you with personalised publishing options including any agreement or offer that you may be eligible for. You can indicate your publishing choice during submission, but you are not required to finalize your choice until after acceptance.
Which institutions are covered by this agreement?
This agreement supports corresponding authors (see FAQ at the bottom of this page) affiliated with a participating JUSTICE member institution.
Which journals are included in this agreement?
Authors can publish eligible articles (see FAQ at the bottom of this page) in a wide variety of participating Elsevier journals across a range of disciplines.
What are the author benefits of publishing open access with Elsevier?
When you publish open access with Elsevier, you get the attention you deserve. We offer authors:
Choice — we have open access journals across every scientific discipline
Support — receive expert support throughout submission, during peer review and post-acceptance
Visibility — your final published article will be published on ScienceDirect, the number one research platform in the world
To learn more about the benefits of publishing open access with Elsevier, please visit our open access author hub.
Are there other publishing options?
Authors can continue to choose to publish under the subscription model, which includes the option to self-archive their manuscript (green open access) in line with Elsevier’s sharing policy.
In addition, Elsevier and JUSTICE have agreed on a pilot to support green open access. Member institutions will be able to benefit from enhanced metadata and links for their institutional repositories, and Elsevier will make Accepted Manuscripts available to non-subscribers, on the ScienceDirect(opens in new tab/window) platform, after an embargo period.
The JUSTICE framework can cover articles with an original submission date between 1 January 2021 and 31 December 2024; however, exact dates depend on each institution’s specific agreement. Please refer to the list of eligible institutions(opens in new tab/window) for exact dates.
The corresponding author is the person who submits the manuscript and other related documentation to the journal and is the primary contact between the journal and all other authors. If the paper is published, the corresponding author is also the first point of contact for readers.
The corresponding author’s responsibilities include:
Ensuring that all authors have complied with the journal’s policies, including reviewing and approving the final version of the manuscript prior to submission
Distributing and responding to communications from the journal (e.g., decision letters, reviewers’ reports)
Completing the post publication author journey including the Journal Publishing Agreement, Rights and Access information form and selection of open access options on behalf of, and with the agreement of, the co-authors
Dealing with any post-publication correspondence (e.g., providing information regarding research data, methods and resources)
For the purposes of the agreement, there is only one corresponding author. All other authors that are not corresponding authors, are called ‘co-authors’.
With this agreement, authors have a choice between a commercial (CC BY) or non-commercial (CC BY-NC-ND) license. The license choice is dependent on the journal selected. Please refer to the journal's homepage for specific details.
The following article types are part of this agreement:
Data in Briefs
Original software publication
For The Lancet journals: Full Length Articles (FLA), Protocols (PRO), and Short Communications (SCO) are part of the agreement.